ChiCTR2300078803
尚未开始
/
/
/
2023-12-19
/
/
抑鬱症
慈心培養小組課程
先導性研究：應用《慈心培養小組課程》於香港專科門診抑鬱症患者
本研究旨在測試一個為期四週以慈心為本的課程，對香港成年抑鬱症患者的成效。
单臂
探索性研究/预试验
九龍東醫院聯網精神科團隊轉介的成年(即18歲或以上)抑鬱症患者，將被招募參加是次計劃。
/
自負盈虧
/
58
/
2023-12-21
2025-01-31
/
1) aged 18 or above 2) outpatients from psychiatric outpatient clinics, who are experiencing major depressive disorder (operationalized as fulfilling the DSM-V criteria and as confirmed by the Mini International Neuropsychiatric Interview (M.I.N.I. 7.0.2. Chinese) (Sheehan et al., 1998; Si et al., 2009)*. The M.I.N.I. 7.0.2 structured clinical interview will be conducted by the researchers to verify the diagnosis upon the referrals are made to the research study. 3) Participants’ concurrent psychotrophic medications would be remained unchanged during the study. * https://harmresearch.org/product/mini-international-neuropsychiatric-interview-mini-7-0-2-14/；
登录查看Patients with neurodevelopmental disorders, schizophrenia spectrum and other psychotic disorders, bipolar disorders, obsessive-compulsive disorders, comorbid substance use disorder, personality disorders, potential risks to self and/or others, suicidal ideation/intended, neurocognitive disorders, intellectual disabilities, physical disabilities, chronic illnesses, who could not read Chinese and speak in Cantonese, who did not read and write, as well as those who had previously attended structured mindfulness-based or structured compassion-based interventions.；
登录查看香港中文大學心理學系
/
约印创投2025-01-16
求实药社2025-01-16
Genhouse2025-01-16
IPHASE2025-01-16
动脉网2025-01-16
动脉网-最新2025-01-16
药明康德2025-01-16
药明康德2025-01-16
再鼎医药2025-01-16
Rimonci2025-01-15
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
